These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1343698)

  • 1. In vitro mutagenesis defines drug targets in aldolase of Plasmodium falciparum.
    Certa U; Itin C; Döbeli H
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():263-4. PubMed ID: 1343698
    [No Abstract]   [Full Text] [Related]  

  • 2. Is Plasmodium falciparum aldolase useful for rational drug design?
    Döbeli H; Itin C; Meier B; Certa U
    Acta Leiden; 1991; 60(1):135-40. PubMed ID: 1820702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular markers related to antimalarial resistance of Plasmodium falciparum and their applications on the surveillance to drug resistance].
    Guan YY; Tang LH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Apr; 23(2):117-20. PubMed ID: 16042182
    [No Abstract]   [Full Text] [Related]  

  • 4. Crystal structure of fructose-1,6-bisphosphate aldolase from the human malaria parasite Plasmodium falciparum.
    Kim H; Certa U; Döbeli H; Jakob P; Hol WG
    Biochemistry; 1998 Mar; 37(13):4388-96. PubMed ID: 9521758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Halo Chloroquine Derivatives Overcome Plasmodium falciparum Chloroquine Resistance Transporter-Mediated Drug Resistance in P. falciparum.
    Edaye S; Tazoo D; Bohle DS; Georges E
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7891-3. PubMed ID: 26438496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
    Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
    Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and cellular localisation of hexokinase during the bloodstage development of Plasmodium falciparum.
    Olafsson P; Certa U
    Mol Biochem Parasitol; 1994 Jan; 63(1):171-4. PubMed ID: 8183319
    [No Abstract]   [Full Text] [Related]  

  • 8. Malaria drug resistance gene identified.
    Walgate R
    Bull World Health Organ; 2000; 78(12):1477. PubMed ID: 11196503
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of novel point mutations in the Plasmodium falciparum ATPase6 candidate gene for resistance to artemisinins.
    Menegon M; Sannella AR; Majori G; Severini C
    Parasitol Int; 2008 Jun; 57(2):233-5. PubMed ID: 18187359
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression, purification, biochemical characterization and inhibition of recombinant Plasmodium falciparum aldolase.
    Döbeli H; Trzeciak A; Gillessen D; Matile H; Srivastava IK; Perrin LH; Jakob PE; Certa U
    Mol Biochem Parasitol; 1990 Jun; 41(2):259-68. PubMed ID: 2204832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates.
    Eldin de Pecoulas P; Abdallah B; Dje MK; Basco LK; le Bras J; Mazabraud A
    Mol Cell Probes; 1995 Dec; 9(6):391-7. PubMed ID: 8808309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare Congolese Plasmodium falciparum DHFR alleles.
    Wilson PE; Kazadi W; Alker AP; Meshnick SR
    Mol Biochem Parasitol; 2005 Dec; 144(2):227-9. PubMed ID: 16183149
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
    Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esterase mutation is a mechanism of resistance to antimalarial compounds.
    Istvan ES; Mallari JP; Corey VC; Dharia NV; Marshall GR; Winzeler EA; Goldberg DE
    Nat Commun; 2017 Jan; 8():14240. PubMed ID: 28106035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pfcrt and pfmdr1 mutations and chloroquine resistance in Plasmodium falciparum from São Tomé and Príncipe, West Africa.
    Lopes D; Nogueira F; Gil JP; Ferreira C; do Rosário VE; Cravo P
    Ann Trop Med Parasitol; 2002 Dec; 96(8):831-4. PubMed ID: 12625938
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of Plasmodium falciparum mutations associated with antimalarial drug resistance during an epidemic in Kuna Yala, Panama, Central America.
    Samudio F; Santamaría AM; Obaldía N; Pascale JM; Bayard V; Calzada JE
    Am J Trop Med Hyg; 2005 Nov; 73(5):839-41. PubMed ID: 16282290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in cg2 and pfcrt genes and resistance to chloroquine and other antimalarials in vitro in Plasmodium falciparum isolates from Colombia.
    González IJ; Varela RE; Murillo C; Ferro BE; Salas J; Giraldo LE; Zalis MG; Saravia NG
    Trans R Soc Trop Med Hyg; 2003; 97(3):318-24. PubMed ID: 15228252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of Plasmodium falciparum aldolase by a tubulin derived peptide and identification of the binding site.
    Itin C; Burki Y; Certa U; Döbeli H
    Mol Biochem Parasitol; 1993 Mar; 58(1):135-43. PubMed ID: 8459825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance.
    Carnevale EP; Kouri D; DaRe JT; McNamara DT; Mueller I; Zimmerman PA
    J Clin Microbiol; 2007 Mar; 45(3):752-61. PubMed ID: 17121999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of chloroquine resistance in Plasmodium falciparum are determined by loci other than pfcrt and pfmdr1.
    Chen N; Russell B; Fowler E; Peters J; Cheng Q
    J Infect Dis; 2002 Feb; 185(3):405-7. PubMed ID: 11807726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.